CXCL10/IP-10: A missing link between inflammation and anti-angiogenesis in preeclampsia?

Francesca Gotsch, Roberto Romero, Lara Friel, Juan Pedro Kusanovic, Jimmy Espinoza, Offer Erez, Nandor Gabor Than, Pooja Mittal, Samuel Edwin, Bo Hyun Yoon, Chong Jai Kim, Shali Mazaki-Tovi, Tinnakorn Chaiworapongsa, Sonia S. Hassan

Research output: Contribution to journalArticlepeer-review

Abstract

Objective. Interferon (IFN)-γ inducible protein, CXCL10/IP-10, is a member of the CXC chemokine family with pro-inflammatory and anti-angiogenic properties. This chemokine has been proposed to be a key link between inflammation and angiogenesis. The aim of this study was to determine whether preeclampsia and delivery of a small for gestational age (SGA) neonate are associated with changes in maternal serum concentration of CXCL10/IP-10. Study design. This cross-sectional study included patients in the following groups: (1) non-pregnant women (N = 49); (2) women with normal pregnancies (N = 89); (3) patients with preeclampsia (N = 100); and (4) patients who delivered an SGA neonate (N = 78). SGA was defined as birth weight below the 10th percentile. Maternal serum concentrations of CXCL10/IP-10 were measured by sensitive immunoassay. Non-parametric statistics were used for analysis. Results. (1) Patients with normal pregnancies had a significantly higher median serum concentration of CXCL10/IP-10 than non-pregnant women (median 116.1 pg/mL, range 40.7-1314.3 vs. median 90.3 pg/mL, range 49.2-214.7, respectively; p = 0.002); (2) no significant correlation was found between maternal serum concentration of CXCL10/IP-10 and gestational age (between 19 and 38 weeks); (3) there were no differences in median serum CXCL10/IP-10 concentrations between patients who delivered an SGA neonate and those with normal pregnancies (median 122.4 pg/mL, range 37.3-693.5 vs. median 116.1 pg/mL, range 40.7-1314.3, respectively; p > 0.05); (4) patients with preeclampsia had a higher median serum concentration of CXCL10/IP-10 than normal pregnant women (median 156.4 pg/mL, range 47.4-645.9 vs. median 116.1 pg/mL, range 40.7-1314.3, respectively; p < 0.05); (5) patients with preeclampsia had a higher median concentration of CXCL10/IP-10 than those who delivered an SGA neonate (median 156.4 pg/mL, range 47.4-645.9 vs. median 122.4 pg/mL, range 37.3-693.5, respectively; p < 0.05). Conclusions. Patients with preeclampsia have significantly higher serum concentrations of CXCL10/IP-10 than both normal pregnant women and mothers who have SGA neonates. These results are likely to reflect an anti-angiogenic state as well as an enhanced systemic inflammatory response in patients with preeclampsia. Alternatively, since preeclampsia and SGA share several mechanisms of disease, it is possible that a higher concentration of this chemokine may contribute to the clinical presentation of preeclampsia in patients with a similar intrauterine insult.

Original languageEnglish
Pages (from-to)777-792
Number of pages16
JournalJournal of Maternal-Fetal and Neonatal Medicine
Volume20
Issue number11
DOIs
StatePublished - 2007
Externally publishedYes

Keywords

  • Angiogenesis
  • Chemokine
  • Chemotactic cytokine
  • CXCL10
  • IP-10
  • Pregnancy
  • SGA
  • Small for gestational age

Fingerprint

Dive into the research topics of 'CXCL10/IP-10: A missing link between inflammation and anti-angiogenesis in preeclampsia?'. Together they form a unique fingerprint.

Cite this